Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
PBF Energy enters the final stretch before its October 29 earnings with the stock up nearly 9% on the week and analysts scrambling to catch up, while the largest shareholder keeps quietly selling into the strength.
The analyst revisions this week tell a striking story of targets lagging behind price. Mizuho raised its target to $89 from $65 on Thursday, maintaining a Neutral rating. Citigroup followed earlier this week with a lift to $91 from $74, also Neutral. Both moves came after the stock had already run past prior targets set just weeks ago. The pattern across the broader coverage universe is the same: nearly every firm that has touched the name since July has raised its target while standing pat on rating. Morgan Stanley has an Underweight at $76. Goldman Sachs sits at Neutral with an $81 target. UBS is the lone bull with a Buy, target $84. The consensus mean sits at $77, now comfortably below the $83.68 close. When the Street's average target trails the market price, the signal is that analysts see value capped even after marking up their numbers.
The borrow market offers no support for a more aggressive short thesis. Short interest has barely moved this week, nudging up just 0.5% to roughly 9.8% of the free float, a level that is meaningful but not alarming. More telling is availability: the lending pool is extremely loose, with available shares running at roughly 4,462% of current short interest, more than 45 shares available for every one already borrowed. Cost to borrow has fallen nearly 30% this week to 0.33%, reinforcing that there is no squeeze pressure or borrow scarcity at work. The put/call ratio is 0.76, modestly above its 20-day average of 0.69 but less than half a standard deviation from the mean. Options traders are slightly more hedged than usual, not defensively positioned. The ORTEX short score has barely shifted, moving from around 48.2 to 48.5 over the past two weeks, consistent with a stock in a short-covering plateau rather than an escalating bear thesis.
The stock's own fundamental picture is genuinely cheap on trailing multiples. The PE is close to 4.5x and the EV/EBITDA is around 3.3x, both of which have compressed further in the past 30 days as the price has risen faster than the multiple. Book value is fractionally below price, with the price-to-book ratio just under 1x. EPS momentum is in the 97th percentile on both 30-day and 90-day measures, meaning near-top-of-universe earnings revision strength. The EPS surprise factor sits at the 81st percentile. The fly in the ointment is 12-month forward EPS growth, which scores only in the 33rd percentile, suggesting the market does not expect earnings growth to continue at the pace of the recent past. That gap between strong trailing momentum and weak forward expectations is the central valuation tension ahead of the Q3 print.
The most consistent seller in the name is Control Empresarial de Capitales, the vehicle of Carlos Slim Helu, which holds a 13D-registered position now at 14.3% of the class, down from 17.3% previously. Since early September it has sold roughly 789,000 shares in open-market transactions at prices ranging from $76 to $84, including two tranches this past week totalling 220,000 shares worth around $18.3 million, none of them under a 10b5-1 plan. The institutional data shows the same entity trimmed by over 3.2 million shares in the most recent reporting period. That is a persistent, discretionary sell programme at a concentrated holder, and it has continued even as the stock has risen. BlackRock, by contrast, added over 619,000 shares in its latest reported period and now holds 10.3% of the class, up from 8.6%. FMR added close to 2.5 million shares. The ownership picture is therefore split: large passive and quant buyers accumulating, while the largest single holder distributes.
The last earnings print, on July 30, produced a one-day gain of 14.1%, before the stock gave back 3.3% over the following five trading days. With Q3 results due October 29, the prior reaction pattern and the widening gap between consensus targets and the current price are the main factors worth watching as refining margins into quarter-end continue to drive the setup.
See the live data behind this article on ORTEX.
Open PBF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
